GLP-1 drugs, initially approved two decades ago for diabetes treatment, have also been found to aid in significant weight loss, impacting over 30 million people in the U.S. positively. However, these medications come with concerning side effects. Experts suggest that GLP-1 drugs might also be beneficial in treating other obesity-related diseases, such as cancer. Correspondent Tracy Smith explores these possibilities and speaks with patients who have experienced a range of reactions to the drugs. The potential of GLP-1 medications to address multiple health issues highlights their importance, but the varied patient experiences underline the need for careful consideration of their use.
QUESTION: How might the discovery of GLP-1 drugs’ additional benefits influence future medical treatments for obesity-related conditions?
The promises and pitfalls of GLP-1 drugs
